New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
10:00 EDTSTJ, LXU, BSX, LGF, ELGX, ABY, ZFGN, EVAR, DWAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with a Neutral at HSBC... Boston Scientific (BSX) initiated with a Neutral at Sterne Agee... DreamWorks Animation (DWA) initiated with a Market Perform at FBR Capital... Endologix (ELGX) initiated with an Outperform at Credit Suisse... LSB Industries (LXU) initiated with a Buy at Feltl... Lionsgate (LGF) initiated with an Outperform at FBR Capital... Lombard Medical (EVAR) initiated with an Outperform at Credit Suisse... St. Jude Medical (STJ) initiated with a Neutral at Sterne Agee... Zafgen (ZFGN) initiated with an Outperform at JMP Securities.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 23, 2015
09:18 EDTLGFOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Tyson Foods (TSN), up 2.4%... Mallinckrodt (MNK), up 7.4%. ALSO HIGHER: Novocure (NVCR), up 16.8% after announcing new Phase 3 data from Optune study... CTI BioPharma (CTIC), up 12.7% after the initiation of its rolling new drug application to the FDA for pacritinib... Peabody Energy (BTU), up 14.8% after announcing an asset sale... Sarepta Therapeutics (SRPT), up 5.2% following a positive mention in Barron's. DOWN AFTER EARNINGS: Trina Solar (TSL), down 5.6%. ALSO LOWER: Par Pacific (PARR), down 13.2% after pricing its 3.4M registered direct offering at $22.00... Lions Gate (LGF), down 2.9% after the "Hunger Games" finale opens below the series average.
08:35 EDTLGFLionsgate shares likely to recover after box office miss, says Piper Jaffray
Subscribe for More Information
07:09 EDTLGFLionsgate estimates lowered below guidance at Stifel
Stifel lowered its estimates for Lionsgate below guidance following a weaker than expected opening last weekend for the company's "Hunger Games: Mockingjay Part 2" film. However, the firm thinks that M&A expectations will somewhat offset the pressure on the stock that will be caused by the film;s weak showing. Stifel keeps a $42 price target and Buy rating on the shares.
November 22, 2015
19:54 EDTLGFAs 'Hunger Games' end, Lionsgate places bets on TV, other media, WSJ says
In the wake of the final installment in its "Hunger Games" film property, Lionsgate is making an "array" of bets across its movie and TV businesses as well as new areas like videogames and live events, reports the Wall Street Journal, citing sources. "The Hunger Games," a dystopic science fiction series starring Jennifer Lawrence, has been a "significant factor" in the rise of Lionsgate shares over the past several years, said the publication, and B. Riley analyst Eric Wold told the Journal that "people have been concerned about this 'Hunger Games' cliff for a long time." Lionsgate hopes its combined initiatives will fill the void represented by the conclusion of the series as well as make up for recent flops like "The Last Witch Hunter," the publication explains. Reference Link
16:22 EDTLGF'Hunger Games' finale opens below series average
Though showing clear dominance in the box office rankings, the final film in the "Hunger Games" saga missed analyst estimates in its domestic open. WEEKEND LEADER: Lionsgate's (LGF) "The Hunger Games: Mockingjay - Part 2" debuted at $101M domestically for the weekend of November 22, missing expectations for $120M-$127M and coming in markedly below the series' $144M first-weekend average. The final entry in the dystopic science fiction tetralogy also saw a weaker open than last year's $121M launch for "Mockingjay - Part 1," though reviews have been slightly stronger. BOX OFFICE RUNNERS-UP: Sony's (SNE) latest James Bond outing "Spectre" slipped to second place at the U.S. box office with $14.6M, while Fox's (FOX, FOXA) "The Peanuts Movie" took in $12.8M. Rounding out the weekend's Top 5 were Sony's "The Night Before" and STX's "The Secret In Their Eyes," with the two newcomers earning a respective $10.1M and $6.6M.
November 20, 2015
16:28 EDTLGFJohn Malone reports 3.3% stake in Lionsgate
Subscribe for More Information
16:23 EDTLGFLiberty Global reports 3.4% stake in Lionsgate
Subscribe for More Information
16:12 EDTLGFLionsgate files to sell 1.52M common shares for holders
11:45 EDTLGFBox Office Battle: 'Hunger Games' finale expected to top box office
Lions Gate's (LGF) "The Hunger Games: Mockingjay - Part 2," the final movie based on the dystopian young adult novels, is opening this weekend at 4,175 theaters and is expecting a domestic gross in the range of $120M-$127M. Piper Jaffray analyst James Marsh said in a note to investors on November 18 that he expects the film to open domestically in the $130M range, above where it is tracking, due to limited competition and the addition of IMAX (IMAX) screens. Piper maintained its Overweight rating and $45 price target on Lions Gate shares at that time. "The Hunger Games" main competition is "Spectre" and "The Peanuts Movie," both of which are in their third weekend of release. Sony's (SNE) "Spectre," starring Daniel Craig as James Bond, is expected to earn another $15.2M-$16.8M. Fox's (FOX, FOXA) G-rated family film, starring a 3D-animated Charlie Brown, is predicted to earn an additional $12.5M-$13.2M. In other box office news, the Wall Street Journal reported that Disney's (DIS) "Star Wars: The Force Awakens," which hits theaters on December 18, has had record-breaking pre-sales. Fandango said the film has already sold more tickets than any other movie before its release, which is still four weeks away, and IMAX said the movie has "doubled" its prior pre-sales record of about $9M. Other publicly traded companies involved in filmmaking include Comcast (CMCSA, CMCSK), Time Warner (TWX), and Viacom (VIA, VIAB).
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
16:05 EDTLGFLionsgate extends contracts of co-COO and Chief Strategic Officer
Subscribe for More Information
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:45 EDTELGXEndologix to present 'positive' Nellix clinical data at VEITH Symposium
Subscribe for More Information
08:02 EDTSTJSt. Jude Medical announces FDA approval of Proclaim Elite SCS system
Subscribe for More Information
07:32 EDTELGX, EVARCanaccord to hold a forum
Subscribe for More Information
November 18, 2015
16:04 EDTELGXEndologix, TriVascular announce early termination of HSR waiting period
Subscribe for More Information
10:01 EDTELGXEndologix to host investor meeting
Investor meeting to be held in New York on November 19 at 6 pm. Webcast Link
07:41 EDTELGXEndologix announces start of physician-initiated registry of Nellix EVAS System
Endologix announced the start of a physician-initiated registry of the Nellix EndoVascular Aneurysm Sealing System, or Nellix EVAS System, used with aortic branch stent grafts for the treatment of patients with complex abdominal aortic aneurysms, or AAAs. The registry, to be conducted outside of the United States, will be called the ASCEND Registry. The primary investigators are Andrew Holden, MD, Associate Professor of Radiology at Auckland Hospital; and Professor Matthew Thompson, MD, Professor of Vascular Surgery, St. Georges Vascular Institute, London. The Nellix System received CE Mark in 2013 for the treatment of patients with infrarenal AAAs. The Nellix System is an investigational device in the United States.
November 17, 2015
10:00 EDTEVAROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
05:45 EDTEVARLombard Medical downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Matthew Taylor downgraded Lombard Medical to Equal Weight citing execution missteps following the pushout of the company's IntelliFlex to at least Q2 of 2016 from Q4. Taylor halved his price target for shares to $2.50 from $5.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use